Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel protein kinase inhibitors for cancer and neurological disorders

Jan. 19, 2004

Morphotek and NCI sign agreement to develop antibodies for the treatment of various cancers

Jan. 19, 2004

Dosing commenced in phase II adult AML trial of clofarabine

Jan. 16, 2004

SB-715992 enters broad phase II program for cancer

Jan. 16, 2004

Novel class of farnesyltransferase inhibitors synthesized by Abbott

Jan. 15, 2004

MPI-176716 produces tumor regression in animal models of ovarian cancer

Jan. 15, 2004

BioStratum and Novo Nordisk to develop antibodies to laminin-5 for cancer

Jan. 15, 2004

Eloxatin approved for first-line treatment of advanced colorectal cancer

Jan. 15, 2004

BMS scientists claim Eg5 inhibitors and their use in cancer therapy

Jan. 15, 2004

Pierre Fabre presents protein prenyltransferase inhibitors for cancer and other disorders

Jan. 15, 2004

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.